Page last updated: 2024-11-04

temozolomide and Friedreich Ataxia

temozolomide has been researched along with Friedreich Ataxia in 1 studies

Friedreich Ataxia: An autosomal recessive disease, usually of childhood onset, characterized pathologically by degeneration of the spinocerebellar tracts, posterior columns, and to a lesser extent the corticospinal tracts. Clinical manifestations include GAIT ATAXIA, pes cavus, speech impairment, lateral curvature of spine, rhythmic head tremor, kyphoscoliosis, congestive heart failure (secondary to a cardiomyopathy), and lower extremity weakness. Most forms of this condition are associated with a mutation in a gene on chromosome 9, at band q13, which codes for the mitochondrial protein frataxin. (From Adams et al., Principles of Neurology, 6th ed, p1081; N Engl J Med 1996 Oct 17;335(16):1169-75) The severity of Friedreich ataxia associated with expansion of GAA repeats in the first intron of the frataxin gene correlates with the number of trinucleotide repeats. (From Durr et al, N Engl J Med 1996 Oct 17;335(16):1169-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lai, Y1
Beaver, JM1
Lorente, K1
Melo, J1
Ramjagsingh, S1
Agoulnik, IU1
Zhang, Z1
Liu, Y1

Other Studies

1 other study available for temozolomide and Friedreich Ataxia

ArticleYear
Base excision repair of chemotherapeutically-induced alkylated DNA damage predominantly causes contractions of expanded GAA repeats associated with Friedreich's ataxia.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Alkylation; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Dacarbazine; DNA Breaks, Single-Str

2014